NASADAD
Search
Primary Menu
Skip to content
Login
Home
About Us
About Us
Board of Directors
NASADAD Staff
Contact Us
Mobile Menus
Search for:
Tag Archives: MAT
♦
NASADAD releases overview of buprenorphine patient limits
♦
February 14, 2017 – NAS/MAT Detox
♦
NASADAD releases fact sheet on neonatal abstinence syndrome
♦
Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers
♦
Methadone maintenance vs. Methadone taper during pregnancy: Maternal and neonatal outcomes
♦
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
♦
Opioid Abuse, Dependence, and Addiction in Pregnancy
♦
Buprenorphine treatment of opioid dependent pregnant women: A comprehensive review
♦
Treatment of Pregnant and Parenting Women: The Use of Medication-Assisted Treatment
♦
Integrating MAT with Primary Care Services for Youth, 5/21/2014
♦
Bupenorphine Treatment for Opioid-Dependent Youth, 4/17/2013
Our Members
Role of State Alcohol and Drug Agencies
NASADAD Annual Meeting
Public Policy
Substance Use Prevention, Treatment and Recovery Services (SUPTRS) Block Grant
NASADAD Fact Sheets
Legislative Summaries
Federal Budget and Appropriations
Letters & Regulatory Comments
NASADAD Presentations
D.C. Updates
Partnerships for Success Information
Hot Topics
State Specific Information
Health Reform Information
Members Only
Prevention
National Prevention Network
NPN Conference
Innovative Substance Abuse Prevention Programs, Practices and Policies
National Prevention Resources
Treatment & Recovery
National Treatment Network
Women’s Services Network
Opioid Treatment Network
HIV Coordinators
Youth Coordinators
State Treatment & Recovery Resources
Resources
NASADAD Reports
Federal Resources
NASADAD Component Groups
Research
Job Postings
Show Member Menus